Rotavirus RP & PPMV1 Vaccine for Pigeons
Formulation: White emulsion with easily dispersible sediments.
Active Substances
Inactivated pigeon rotavirus (Ro/D strain)
Inactivated pigeon paramyxovirus type 1 (PPMV1), strain 988M ≥ 6.47 Haemagglutination
Adjuvants
Paraffin oil: 156.9 mg
Sorbitan oleate: 15.8 mg
Polysorbate 80: 5.7 mg
Excipients
Thiomersal (max. 0.036 mg)
Indications (Use)
For active immunisation of pigeons from the 4th week of life:
To reduce clinical signs, pathological lesions, and viral spread caused by pigeon rotavirus group A, G18P|17 genotype (PiRV).
To reduce mortality and clinical symptoms caused by paramyxovirus type 1 (PMV1).
Onset & Duration of Immunity
Immunity begins: 2 weeks after completing the primary vaccination schedule
Duration of immunity:
PiRV: 8 months
PMV1: 9 months
(demonstrated by challenge with virulent virus)
Instructions for Use
Dosage: 0.3 ml per pigeon
Administration: Intramuscular injection
Insert the needle at an acute angle, not perpendicular
Preparation:
Shake before and occasionally during use
Allow vaccine to reach room temperature
Use aseptic technique with sterile syringes and needles
Use properly graded syringes to ensure accurate dosing
📌 Note: Always read and follow the full product leaflet for detailed vaccination schedules, booster intervals, contraindications, and withdrawal times.